pfizer news - Search News

RSV, Pfizer

US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease

The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease.

The Wall Street Journal on MSN · 2h

Pfizer Receives FDA Approval for RSV Vaccine

Abrysvo can prevent lower respiratory tract disease caused by RSV for people between the ages of 18 and 59 who are at increased risk. It is the first RSV vaccine indicated for adults younger than 50,

YAHOO!Finance · 2h

U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults Aged 18 to 59 at Increased Risk for Disease

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO® (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine,

Seeking Alpha on MSN · 1h

Pfizer RSV vaccine Abrysvo gains expanded indication

The U.S. FDA has approved Pfizer's respiratory syncytial virus vaccine Abrysvo for individuals 18 to 59 years old that are at increased risk of lower respiratory tract disease from the virus. Those conditions include obesity,

Pfizer, Starboard Value

FiercePharma · 8h

UPDATED: Starboard wants to hold Pfizer leadership 'accountable' for overpaid M&A deals, poor return on R&D investment

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job. | Activist investor Starboard Value is baring its teeth at Pfizer management,

The Financial Times · 7h

Starboard calls for Pfizer board to ‘hold management accountable’

Jeff Smith says pharma giant’s returns from recent efforts are ‘not adequate’ in speech at 13D activist investor conference

Reuters on MSN · 8h

Starboard Value CEO says Pfizer's board should hold management accountable

Activist hedge fund Starboard Value's chief investment officer Jeffrey Smith said on Tuesday that drugmaker Pfizer Inc's board needs to hold management accountable for its underperformance. "We measure success in producing blockbuster drugs and we all get measured by our track records.

What activist hedge fund Starboard wants from Pfizer

Starboard's Jeff Smith told Pfizer in a meeting last week that they need to improve their return on investments in R&D and ...

Activist Investor Starboard Slams Pfizer for Underperforming R&D And Overpaying for Acquisitions

Starboard Value criticizes Pfizer's leadership for underperformance, citing a 50% stock decline and missed growth targets ...

FiercePharma2h

Pfizer lays off 75 more workers in North Carolina in wake of late-stage DMD trial fail

Pfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. | Pfizer has told 75 ...

STAT9h

Pharmalittle: We’re reading about a probe of Pfizer and Lilly telehealth, pharma exec donations, and more

Dick Durbin (D-Ill.) demanded answers from Pfizer and Eli Lilly about their relationships with the telehealth prescribers ...

BioPharma Dive7h

Starboard makes case for change at Pfizer, citing research, M&A missteps

The activist investor claims Pfizer failed to capitalize on the windfall earned from its COVID-19 vaccine and, in the process, destroyed tens of billions of dollars in market value.

Starboard Scolds Pfizer Over $20 Billion Value Destruction (1)

Starboard Value LP Chief Executive Officer Jeffrey Smith said there has been at least $20 billion in value destruction at drugmaker Pfizer Inc., which he admonished for failing to deliver on a ...

STAT15h

Senators demand answers on telehealth platforms from Pfizer and Eli Lilly

Led by Sen. Dick Durbin of Illinois, senators question if direct-to-consumer website telehealth deals are a new way around ...

10h

Starboard Chief Criticizes Pfizer’s R&D Investments

Activist hedge fund Starboard Value believes the root cause of Pfizer’s issues are the low expected returns on its R&D investments, including investments done both internally and through M&A.

Investor's Business Daily on MSN3h

Starboard Hammers Pfizer Execs For Failing To Deliver On 'Best Pipeline' Promises

Starboard took aim at Pfizer in another blow Tuesday, saying the company has failed to deliver on what it called the "best ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

RSV, Pfizer

Pfizer, Starboard Value

Related topics